AngioDynamics Inc (FRA:UG2)
€ 6.15 -0.1 (-1.67%) Market Cap: 251.87 Mil Enterprise Value: 205.71 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 66/100

Q1 2024 AngioDynamics Inc Earnings Call Transcript

Oct 04, 2023 / 12:00PM GMT
Release Date Price: €6.95 (-2.80%)
Operator

Good morning, and welcome to the AngioDynamics Fiscal Year 2024 First Quarter Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

The news release detailing AngioDynamics' fiscal 2024 first quarter results crossed the wire earlier this morning and is available on the company's website. This conference call is also being broadcast live over the Internet at the Investors section of the company's website at www.angiodynamics.com, and the webcast replay of the call will be available at the same site approximately 1 hour after the end of today's call.

Before we begin, I would like to caution listeners that during the course of this conference call, the company will make projections or forward-looking statements regarding future events, including statements about expected revenue, adjusted earnings, and gross margins for fiscal year 2024 as well as trends that may continue. Management encourages you to review the company's past and future filings with the SEC, including,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot